Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Other Working Capital Changes (2023 - 2025)

Historic Other Working Capital Changes for Immunocore Holdings (IMCR) over the last 3 years, with Q3 2025 value amounting to $9.3 million.

  • Immunocore Holdings' Other Working Capital Changes rose 39951.4% to $9.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.4 million, marking a year-over-year decrease of 7071.23%. This contributed to the annual value of $11.6 million for FY2024, which is 2272.85% down from last year.
  • Immunocore Holdings' Other Working Capital Changes amounted to $9.3 million in Q3 2025, which was up 39951.4% from -$5.1 million recorded in Q2 2025.
  • Over the past 5 years, Immunocore Holdings' Other Working Capital Changes peaked at $33.1 million during Q4 2023, and registered a low of -$18.1 million during Q1 2023.
  • For the 3-year period, Immunocore Holdings' Other Working Capital Changes averaged around $2.9 million, with its median value being $1.9 million (2024).
  • Data for Immunocore Holdings' Other Working Capital Changes shows a peak YoY increase of 39951.4% (in 2025) and a maximum YoY decrease of 32778.03% (in 2025) over the last 5 years.
  • Quarter analysis of 3 years shows Immunocore Holdings' Other Working Capital Changes stood at $33.1 million in 2023, then crashed by 82.79% to $5.7 million in 2024, then soared by 62.58% to $9.3 million in 2025.
  • Its last three reported values are $9.3 million in Q3 2025, -$5.1 million for Q2 2025, and $1.6 million during Q1 2025.